SAN FRANCISCO, Aug. 13, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Evolent Health, Inc. (NYSE: EVH) to the securities class action, Plymouth County Retirement System v. Evolent Health, Inc. et al., No. 1:19-cv-01031 pending in the U.S. District Court for the Eastern District of Virginia.

SOUTH SAN FRANCISCO, Calif., Aug. 13, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) today announced the pricing of its underwritten public offering of 8,035,715 shares of its common stock at a price to the public of $28.00 per share. In addition, the underwriters of the offering have been granted a 30-day option to pu

DALLAS and COLUMBIA, Md., Aug. 13, 2019 /PRNewswire/ -- CRISP, the designated health information exchange (HIE) covering patients across Maryland and the District of Columbia, today announced the expansion of its technical integration with ADVault, Inc., the global lea

STAINES-UPON-THAMES, United Kingdom, Aug. 13, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global biopharmaceutical company, today announ

NEW YORK and BERKELEY HEIGHTS, N.J., Aug. 13, 2019 /PRNewswire/ -- CityMD, the leading urgent care provider in the New York metro area, and Summit Medical Group, one of the nation's premier independent multispecialty medical practices, today announced the completion of their merger – the first-of-its-kind between an urgent care

NEW YORK, Aug. 13, 2019 /PRNewswire/ -- The Alzheimer's Foundation of America (AFA) today announced a

WARSAW, Ind., Aug. 13, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Wells Fargo Securities 2019 Healthcare Conference at the Westin Copley Place in Boston.  Cole Lannum, CFA, Senior Vice President of Investor Relations, will present for the

WARRINGTON, Pa., Aug. 13, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation f

DENVER, Aug. 13, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "Company"), today announced that the Company will host a conference call to discuss operational and financial highlights from its second quarter 2019 on Thursday, August 15, 2019 at 4:15 p.m. ET

RANCHO CORDOVA, Calif., Aug. 13, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced improved financial and operating results for the second quarter ended June 30, 2019 and provided a corpor